[Pharmacoeconomics of molecular targeting drugs]

Nihon Rinsho. 2014 Jun;72(6):1157-62.
[Article in Japanese]
No abstract available

MeSH terms

  • Cost-Benefit Analysis
  • Decision Making
  • Molecular Targeted Therapy / economics*